1. Introduction {#sec1-ijerph-15-00363}
===============

Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality and the fourth leading cause of death worldwide \[[@B1-ijerph-15-00363]\]. Cigarette smoking is generally considered the most important risk factor of COPD, although several other risk factors have been described \[[@B2-ijerph-15-00363]\]. Previous studies have associated air pollution, especially ambient particulate matter and nitrogen dioxide (NO~2~), with the prevalence of COPD and reduced lung function in adults \[[@B3-ijerph-15-00363],[@B4-ijerph-15-00363],[@B5-ijerph-15-00363]\]; a few studies have examined the effects of air pollution on objective measurements of lung function in adults \[[@B6-ijerph-15-00363],[@B7-ijerph-15-00363]\]. The relationship between air pollution and lung function is further complicated by the existence of effect modifiers. Demographic and lifestyle factors have been reported to modify the association between air pollutants and lung function \[[@B8-ijerph-15-00363],[@B9-ijerph-15-00363],[@B10-ijerph-15-00363],[@B11-ijerph-15-00363],[@B12-ijerph-15-00363]\], but the findings remain inconsistent; some studies did not find any effect modification \[[@B4-ijerph-15-00363],[@B13-ijerph-15-00363],[@B14-ijerph-15-00363]\].

Some cross-sectional studies have reported links between traffic-related air pollution, such as particulate matter (aerodynamic diameter of ≤10 μm (PM~10~) and ≤2.5 μm (PM~2.5~)) and NO~2~, and COPD in adults, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria \[[@B15-ijerph-15-00363],[@B16-ijerph-15-00363]\]. However, other cross-sectional studies reported no association between traffic-related air pollution and COPD prevalence \[[@B17-ijerph-15-00363],[@B18-ijerph-15-00363]\]. Nevertheless, the majority of studies conducted on the relationship between traffic-related air pollution and lung function found that reduced lung function (a predictor of COPD mortality and morbidity) was associated with air pollution in adults \[[@B17-ijerph-15-00363],[@B19-ijerph-15-00363]\], though others have failed to detect an association between air pollution and lung function \[[@B18-ijerph-15-00363],[@B20-ijerph-15-00363]\]. Cohort studies have reported some evidence of an association between air pollution and COPD \[[@B21-ijerph-15-00363],[@B22-ijerph-15-00363],[@B23-ijerph-15-00363]\]. The European Study of Cohorts for Air Pollution Effects (ESCAPE) showed a significant positive association between air pollution and GOLD-defined COPD only in females \[[@B24-ijerph-15-00363]\]. Recent reviews of the literature have provided only suggestive evidence of associations between long-term exposure to air pollution and the prevalence and incidence of COPD (as defined by the GOLD criteria) among adults \[[@B2-ijerph-15-00363],[@B23-ijerph-15-00363],[@B25-ijerph-15-00363]\].

The limited number of studies and conflicting results highlight a need for more research on the relationship between air pollution and lung function in adults. Some studies conducted on this topic in Europe, North America, and China may not be applicable in Korea because of meaningful differences between health status characteristics, socioeconomic factors, and pollutant levels. In addition, it is also necessary and important to examine whether demographic and lifestyle factors modify the relationship between air pollution and lung function. Increased knowledge on the effect modification of these factors may lead to an enhanced understanding of an air pollution--health relation thought to have large population health impacts.

In this study, we investigated the long-term effects of ambient particulate matter (PM~10~ and PM~2.5~) and NO~2~ on lung function and COPD using the GOLD criteria. We further examined whether demographic and lifestyle factors (age, education, sex, smoking, physical activity, and body mass index) modify this relationship by a stratified analysis.

2. Materials and Methods {#sec2-ijerph-15-00363}
========================

2.1. Study Population {#sec2dot1-ijerph-15-00363}
---------------------

This study was based on all available spirometry tests from the period January 2014 to December 2015 from a university hospital. When subjects visited the university hospital with respiratory symptoms and were suspected to have an underlying chronic respiratory condition (e.g., COPD or asthma), the subjects were suggested for spirometry testing. The study eligibility criteria were: an age between 20 and 85 years and residing in Seoul and Incheon (South Korea). Demographic information, lifestyle information, family history, and previous medical history were obtained using a self-administered questionnaire, and clinical data were obtained from medical records. A total of 1274 participants agreed to participate. We excluded participants with an active respiratory infection, an acute illness of any kind, or COPD (n = 9) or for whom no information on residential address was available (n = 1). Accordingly, the data of 1264 subjects were included in the analysis ([Figure S1](#app1-ijerph-15-00363){ref-type="app"}). Written informed consent was obtained from all participants after they had been fully informed of the survey protocol. The study protocol was approved by the Institutional Review Boards of Inha University Hospital.

2.2. Spirometry {#sec2dot2-ijerph-15-00363}
---------------

Spirometry was conducted by a trained field technician using a portable microspirometer (Microspiro HI-298, Tokyo, Japan) according to the guidelines issued by the American Thoracic Society (ATS) \[[@B26-ijerph-15-00363]\]. COPD was defined using the GOLD criteria, that is, as a forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio of \<70%.

2.3. Exposure Assessment {#sec2dot3-ijerph-15-00363}
------------------------

Exposure to air pollution was assessed based on geo-coded residential addresses. Concentrations of PM~2.5~, PM~10~, and NO~2~ at residential addresses were estimated using land-use regression (LUR) models using a previously described standardized method \[[@B27-ijerph-15-00363]\]. In brief, we modeled air pollutants using LUR models and a regulatory monitoring network, and used ambient concentrations of PM~2.5~, PM~10~, and NO~2~ in the study area. [Figure 1](#ijerph-15-00363-f001){ref-type="fig"} shows the distribution of monitoring stations and study participants. We obtained hourly PM~10~, PM~2.5~, and NO~2~ concentrations measured at the 60 fixed monitoring stations in the study area (Seoul and Incheon) from the Korean Ministry of Environment (<http://www.airkorea.or.kr/eng/information/stationInformation>). There are four types of monitoring site in Korea: urban background, urban roadside, regional background, and national background. Measurements of air pollutants in our study were conducted at urban background monitoring sites.

Given the hourly measurements of PM~10~, PM~2.5~, and NO~2~, we computed daily averages for the days when the hourly measurements were recorded for more than 75% (18 hours) of the day. Then, the annual averages were calculated for the sites that had more than 75% (274 days) of daily data. We used centrally and locally available geographic variables as potential predictors. Predictor variables, such as traffic indicators, surrounding-land usage, topography, and spatial trends, were computed at each location using ArcGIS version 9.3 (a geographic information system) (ESRI, Redlands, CA, USA). Multiple linear regression models were built using a supervised forward stepwise procedure. Predictor variables used in the final LUR model for air pollution included the lengths of all roads within 300 m of residences, traffic intensity on nearest roads, total heavy-duty traffic loads of all roads within 100 m, urban green area within 300 m, and a variable representing spatial trends. The models explained 53--79% of the variability in measured PM~2.5~, PM~10~, and NO~2~ levels, depending on the validation method used, and the predicted values fitted well with the measured values, as reported in our previous study \[[@B28-ijerph-15-00363]\].

To assess the effects of exposure duration on COPD and lung function, we calculated one-year average concentrations for the year of the investigation (which was from 2014 to 2015) and three- and five-year average concentrations for the preceding three years and four years of the investigation, respectively.

2.4. Statistical Analysis {#sec2dot4-ijerph-15-00363}
-------------------------

Initially, we performed a logistic regression analysis to examine associations between exposure variables (PM~2.5~, PM~10~, and NO~2~) and COPD. Then, we investigated relations between exposure variables and lung function outcome using linear regression; results are presented as β-values and 95% confidence intervals (CIs). Air pollution concentrations were entered as continuous variables without transformation and results are presented as change in outcome per 10 μg/m^3^ increase in exposure. For the logistic regression analysis, tertiles were calculated for each air pollutant level. Final models were adjusted for age (years), sex, education (\<high school, high school, \>high school), smoking status (current, former, non-smoker), body mass index (BMI), drinking status (yes and no), physical activity (yes and no), hypertension (yes and no), diabetes mellitus (yes and no), hyperlipidemia (yes and no), history of stroke (yes and no), family history of COPD (yes and no), family history of asthma (yes and no), and history of angina pectoris (yes and no). These covariates were selected based on previously reported results by applying a forward elimination procedure.

We also performed stratified analyses by age (\<50th percentile and ≥50th percentile of age), BMI groups (50th percentile and ≥50th percentile), sex (male and female), regular physical activity (yes and no), smoking status (current, former, and non-smoker), and education (\<high school and ≥high school). Effect modifications by these factors in association with each pollutant and lung function were calculated by including an interaction term. All analyses were performed using STATA 13.

3. Results {#sec3-ijerph-15-00363}
==========

[Table 1](#ijerph-15-00363-t001){ref-type="table"} shows the proportion of participants with each categorical potential risk variable and the adjusted odds ratios (ORs) and CIs for each variable. Of the 1264 study participants, 683 (54%) were female and 581 (46%) were male, and the average age was 57.9 years. We identified 94 participants (7.4%) with clinically diagnosed COPD based on a post-bronchodilator FEV1/FVC of \<0.7. Older age and smoking appeared to be strongly associated with higher odds of COPD. People aged 70 years or older (adjusted OR (aOR) = 3.14 (95% CI: 1.25--7.91) showed an increased risk of COPD compared with people aged less than 50 years of age. Likewise, the risk of COPD was higher in current and former smokers compared with non-smokers. None of the other risk variables were statistically significantly associated with COPD.

The distributions of the one-, three-, and five-year mean particulate and NO~2~ air concentrations are summarized in [Table 2](#ijerph-15-00363-t002){ref-type="table"}. The ranges of pollutant concentrations represent data from all of the regulatory monitors combined. The mean concentration for PM~2.5~, PM~10~, and NO~2~ in the study areas during the study period appeared to be consistent. The five-year annual mean concentrations were 35.8 μg/m^3^, 53.6 μg/m^3^, and 45.6 μg/m^3^ for PM~2.5~, PM~10~, and NO~2~, respectively. The ranges of particulate matters were smaller than that of NO~2~. There were weak correlations between PM~2.5~ and PM~10~, but these particulate matters were not correlated with NO~2~.

[Table 3](#ijerph-15-00363-t003){ref-type="table"} shows the ORs of the three-year mean particulate and NO~2~ air concentrations with COPD. The ORs for the annual mean and the five-year mean of these pollutants can be found in the [supplementary file (Table S1)](#app1-ijerph-15-00363){ref-type="app"}. Logistic regression analysis showed that the highest tertile of NO~2~ exposure (three-year mean) was significantly associated with COPD, with aOR = 1.83 (95% CI: 1.04--3.21) for the highest tertile (≥53.8 μg/m^3^) compared with the lowest tertile (\<41.0 μg/m^3^). Similar results were observed for PM~2.5~ (highest versus lowest tertile: aOR = 1.79 (95% CI: 1.02--3.13), whereas the result for PM~10~ was marginally significant (highest versus lowest tertile: aOR = 1.57 (95% CI: 0.92--2.69; *p* = 0.099). Furthermore, a 10 μg/m^3^ increase in NO~2~ concentration (three-year mean) appeared to be significantly associated with COPD (aOR = 1.14, 95% CI: 1.00--1.30 per 10 μg/m^3^ increase) and positive, but not statistically significant, associations were observed for PM~2.5~ and PM~10~. Results for the three-year mean of air pollutants did not change substantially when the pollutant levels were averaged for five-year periods. However, the dose-response relationship of the five-year mean of PM~2.5~ was not significant (*p* for trend =0.126). The association between PM~10~ and NO~2~ and COPD was stronger for the three- and five-year mean than for the annual mean, and the one-year average PM~2.5~ values showed variable associations with COPD ([Table S1](#app1-ijerph-15-00363){ref-type="app"}).

The results of linear regression analysis of the effects of PM~10~, PM~2.5~, and NO~2~ on lung function are shown in [Table 4](#ijerph-15-00363-t004){ref-type="table"}. In adjusted models, significant negative associations were observed between exposure to PM~10~ (3-year average) and FVC (β = --1.73; 95% CI: --3.35 to --0.12 per 10 μg/m^3^ increase in PM~10~) and FEV~1~ (β = --1.85; 95% CI: --3.65 to --0.05 per 10 μg/m^3^ increase in PM~10~). Likewise, an inverse, significant association was found between annual average PM~10~ level and FVC. NO~2~ and PM~2.5~ showed no significant associations with FVC or FEV~1~. Although COPD as defined by FEV1/FVC \<0.7 was associated with higher levels of PM~2.5~ or NO~2~, none of the pollutants considered in this study demonstrated a significant association with the FEV~1~/FVC ratio.

We also examined the effects of air pollutant on lung function (FVC and FEV1) in different subgroups ([Table 5](#ijerph-15-00363-t005){ref-type="table"}). Age and education were potential modifiers of the association between PM~10~ exposure and FEV1 decline (*p* values for interactions \<0.01). The adverse effect of PM~10~ on lung function was greater in participants aged ≥57 years than in those aged \<57 years. Similarly, the effect of PM~10~ on lung function was greater among less-educated participants. To test the possibility of whether age and education were associated with FEV1 decline independent of exposure to PM~10~ in this study population, we constructed new models for education with and without interaction with age. In the adjusted model (adjusted for all confounders as described in the footnotes of [Table 5](#ijerph-15-00363-t005){ref-type="table"}) without an interaction term, lower level of education and older age were not associated with FEV1 decline. Furthermore, there was no interaction between education and age. This indicates that people with different levels of education and age did not differ in rate of FEV1 decline. Although interactions were not statistically significant, PM~10~ tended to have a stronger effect on FVC in male (β = --2.69; 95% CI: --4.92, --0.46) and former smokers (β = --3.61; 95% CI: --6.93, --0.29). Furthermore, the adverse effect of PM~2.5~ on lung function was greater among those that did not exercise.

A plot of association of PM~10~, PM~2.5~, and NO~2~ with COPD prevalence in different subgroups appears in [Figure 2](#ijerph-15-00363-f002){ref-type="fig"}. The association of COPD with NO~2~ and PM~2.5~ was greatest for older people. The PM~2.5~ model showed a stronger association with COPD for males. The association of PM~2.5~ with COPD was greatest in current smokers and was smaller in former and non-smokers. For PM~10~ and NO~2~, the associations showed the opposite pattern, but all 95% CIs were compatible with the null.

4. Discussion {#sec4-ijerph-15-00363}
=============

In the present study, higher levels of PM~2.5~ and NO~2~ were significantly associated with increased COPD prevalence in adults using GOLD criteria. In addition, PM~10~ concentration showed significant negative associations with FVC and FEV~1~, and PM~10~ generally had stronger effects in older and less educated participants. The associations of COPD with PM~2.5~ were strongest in men, older adults, and in current smokers. FEV~1~ and FVC were not associated with PM~2.5~ and NO~2~ concentrations, and none of the three pollutants was associated with FEV~1~/FVC ratio.

Our findings that PM~2.5~ and NO~2~ were associated with the risk of GOLD-defined COPD in adults agree with those of other cross-sectional studies, which reported that COPD was positively associated with chronic exposure to PM and NO~2~ and living near a major road \[[@B3-ijerph-15-00363],[@B15-ijerph-15-00363],[@B16-ijerph-15-00363]\]. In an Italian study by Nuvolone et al. (2011), a positive association was reported between COPD and living within 100 m of a major road (aOR = 2.07, 95% CI: 1.11--3.87) in males only \[[@B16-ijerph-15-00363]\]. A study performed on 4757 women living in the Rhine-Ruhr Basin found that a 5-year mean increase of 16 μg/m^3^ in NO~2~ was significantly associated with the risk of COPD (OR = 1.39, 95% CI: 1.20--1.63), and that women living less than 100 m from a busy road were 1.79 times (95% CI: 1.06--3.02) more likely to have COPD than those living farther away \[[@B15-ijerph-15-00363]\]. A recent study in China reported that elevated PM~2.5~ levels were probably associated with the prevalence COPD (adjusted OR 2.42, 95% CI: 1.42--4.12, for \>30 and ≤75 μg/m^3^ compared with a lower level of ≤35 μg/m^3^) \[[@B3-ijerph-15-00363]\]. Furthermore, our finding of a nonsignificant positive relationship between PM~10~ and COPD concurs with that of a previous study, in which exposure to PM~10~ non-significantly increased the risk of COPD \[[@B15-ijerph-15-00363]\]. On the other hand, some cross-sectional studies found no association between air pollution and COPD in adults \[[@B17-ijerph-15-00363],[@B18-ijerph-15-00363]\].

Available evidence strongly supports that chronic air pollution reduces lung function in children, but the majority of such studies in adults have been conducted on susceptible populations \[[@B19-ijerph-15-00363],[@B29-ijerph-15-00363]\]. Our finding that PM~10~ has an adverse effect on lung function in adults is in line with the observations that FVC and FEV~1~ are negatively associated with traffic-related air pollution \[[@B3-ijerph-15-00363],[@B5-ijerph-15-00363],[@B9-ijerph-15-00363],[@B24-ijerph-15-00363],[@B25-ijerph-15-00363]\]. In a recent ESCAPE study, an association was observed between exposure to PM~10~ and NO~2~ and reduced FVC and FEV \[[@B19-ijerph-15-00363]\], but average levels of PM~10~ (25 μg/m^3^) were much lower than those observed in the present study (51--54 μg/m^3^). Furthermore, as was reported in two previous studies \[[@B17-ijerph-15-00363],[@B18-ijerph-15-00363]\], we did not observe a significant association between NO~2~ level and any spirometric parameter. In addition, no association was observed between any of the three pollutants and a reduction in FEV1/FVC ratio, as has been previously reported \[[@B12-ijerph-15-00363],[@B15-ijerph-15-00363],[@B30-ijerph-15-00363],[@B31-ijerph-15-00363]\]. Some of the discrepancies between reported associations between air pollution and COPD or lung function may have been due to different exposure assessment durations \[[@B32-ijerph-15-00363]\].

The observed interactions between PM~10~ and age and education on lung function (FEV~1~ and FVC) agree with observations made in recent studies, which reported that age and education modify the relationship between air pollution and respiratory health \[[@B33-ijerph-15-00363],[@B34-ijerph-15-00363]\]. Studies have also demonstrated an association between age and lung function, and suggested that an advanced age is associated with reduced lung function \[[@B11-ijerph-15-00363]\]. The effect of air pollution (PM~10~ or ozone) on lung function is more prominent among the elderly \[[@B35-ijerph-15-00363],[@B36-ijerph-15-00363]\], and thus PM~10~ and age act synergistically to reduce lung function. This may be due to a cohort effect or older people being more susceptible to air pollution effects on lung function. Our finding that education modified relationships between PM~10~ or PM~2.5~ and lung function is supported by Cakmak et al. (2016), who found that a lower education increased lung function impairment resulting from exposure to PM~10~ \[[@B33-ijerph-15-00363]\]. Moreover, among our subjects that did not exercise, PM~2.5~ appeared to have stronger negative effects on lung function, which suggests that physical activity has a beneficial effect. This finding is consistent with that of a previous study, which investigated the protective effect of physical activity on particulate air pollution-induced pulmonary response \[[@B8-ijerph-15-00363]\].

As would be expected, current smokers had the strongest association between COPD and PM~2.5~. The finding of the strongest association between FVC and PM~10~ among former smokers is unable to be described. Although it was unlikely to be due to subjects with lung disease giving up smoking, it is possible that former smokers with COPD may retain a propensity to the adverse effect of PM~10~.

The mechanism responsible for the effect of chronic exposure to air pollution on COPD in adults is unknown, but oxidative stress and pulmonary inflammation have been suggested to be main mechanisms in animal studies \[[@B37-ijerph-15-00363],[@B38-ijerph-15-00363]\]. We found that NO~2~ and PM~2.5~ were associated with COPD prevalence. NO~2~ is considered to be an airway irritant that potentially interacts with the immune system to cause respiratory tract infections and promote lung inflammation \[[@B39-ijerph-15-00363]\]. Chronic exposure to PM~2.5~ may have an irritative effect on airways and trigger inflammatory response in lung tissue \[[@B40-ijerph-15-00363]\]. It has also been suggested that reactive oxygen species and free radicals generated in response to NO~2~ and PM~2.5~ can overwhelm the redox system and damage cell-wall lipids, proteins, and DNA, thereby inducing airway inflammation \[[@B41-ijerph-15-00363]\].

The present study has three strengths: 1) the exposure variables used were computed using geographic information system (GIS) tools at participants' addresses, whereas postcodes have been used in many previous studies; 2) An objective definition of COPD was used; and 3) We evaluated the potential effect modifier by a stratified analysis, and all results were adjusted for many potential confounders. However, the study also has its limitations. First, the ideal definition of COPD remains controversial \[[@B42-ijerph-15-00363],[@B43-ijerph-15-00363]\]. In this study, we used the GOLD definition (FEV1/FVC \<0.7), which is considered as a key guideline in the management of COPD. However, the accuracy of lung function criteria for the diagnosis of COPD in the elderly has been questioned \[[@B44-ijerph-15-00363]\]. This may lead to an overdiagnosis of COPD in very old people. Nevertheless, previous studies have suggested that COPD may be either overdiagnosed or underdiagnosed depending on the approach taken to defining abnormal lung function \[[@B43-ijerph-15-00363],[@B45-ijerph-15-00363]\]. In addition, in our study, the diagnosis of COPD is based on a single initial spirometry test, as stated in the current international clinical COPD guideline \[[@B46-ijerph-15-00363]\]. A recent study found that a substantial proportion of subjects (15.1%) shifted diagnostic category (obstructed/non-obstructed) by 1 year when using spirometry (fixed ratio) as a cut-off \[[@B47-ijerph-15-00363]\]. Future studies need to consider the short-term or long-term consistency of a spirometric diagnosis of airway obstruction while examining the association of air pollution with COPD in this study population. Second, our exposures were estimated by an LUR model. Although LUR models provide fine-scale spatial estimates for air pollution \[[@B48-ijerph-15-00363]\], they are subject to the spatial effects associated with the properties of spatial data. LUR models may give extremely high or low predictions when the distribution of selected variables across residences falls outside the range of the monitoring sites \[[@B49-ijerph-15-00363]\]. However, we used 60 sampling locations to develop the LUR models. The inclusion of these locations would have increased exposure contrast. Hoek et al. \[[@B48-ijerph-15-00363]\] suggested a minimum of 40--80 sampling locations in order to properly specify an urban LUR model. Third, our exposure variables were based on current home addresses, and thus some degree of exposure misclassification may have occurred when subjects moved to other locations. However, this probably only affected a limited number of individuals and resulting misclassifications were likely to be nondifferential. Fourth, despite the extent of the adjustment performed for multiple covariates, such as demographic characteristics, lifestyle, health-related factors, and cigarette smoking, unmeasured factors, such as levels of aeroallergens (pollen, fungus, and dust mites), may have confounded the effect of air pollutants on lung function. However, as our study is restricted to non-asthmatic adults, the potential confounding effect of airway sensitization is minimal. Finally, the cross-sectional nature of the present study precludes definitive statements on causal relationships.

5. Conclusions {#sec5-ijerph-15-00363}
==============

Chronic exposure to PM~2.5~ and NO~2~ was found to be associated with higher COPD prevalence in adults. The results obtained also suggest that exposure to particulate air pollution is associated with reduced lung function, that PM~10~ exposure is associated with lower FVC and FEV~1~ values, and that the effects of PM~10~ exposure are greater in the elderly and in those with a low level of education. Furthermore, an association was observed between PM~2.5~ exposure and lower FVC and FEV~1~ in subjects that did not exercise. On the other hand, NO~2~ was not found to influence lung function in all participants or by a stratified analysis. Further research is needed to determine whether pollutant types differentially affect lung function.
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###### 

Potential risk variables for study participants (n = 1264).

  --------------------------------------------------------------------------------------------------
  Variable                     n (%) or mean ± SD   COPD (n)   Prevalence (%)   Adjusted \*\
                                                                                OR (95% CI)
  ---------------------------- -------------------- ---------- ---------------- --------------------
  Sex                                                                           

  Female                       683 (54.03)          30         4.39             Reference

  Male                         581 (45.97)          64         11.02            1.20 (0.53--2.74)

  Age, years                                                                    

  \<50                         225 (17.80)          12         5.33             Reference

  50--59                       527 (41.69)          31         5.88             1.36 (0.66--2.78)

  60--69                       380 (30.06)          37         9.74             2.69 (1.25--5.78)

  ≥70                          132 (10.44)          14         10.61            3.14 (1.25--7.91)

  Education                                                                     

  \<High school                341 (26.98)          22         6.45             Reference

  High school                  503 (39.79)          43         8.55             1.39 (0.77--2.50)

  \>High school                420 (33.23)          29         6.90             1.07 (0.56--2.02)

  BMI                                                                           

  \<18.5                       17 (1.34)            1          5.88             Reference

  18.5--25                     799 (63.21)          69         8.64             0.81 (0.10--6.51)

  \>25                         448 (35.44)          24         5.36             0.42 (0.05--3.53)

  Smoking                                                                       

  Non-smoker                   796 (62.97)          34         4.27             Reference

  Former smoker                291 (23.02)          34         11.68            2.52 (1.09--5.81)

  Current smoker               177 (14.00)          26         14.69            4.33 (1.84--10.22)

  Drinking                                                                      

  No                           672 (53.16)          40         5.95             Reference

  Yes                          592 (46.84)          54         9.12             1.01 (0.59--1.72)

  Exercise                                                                      

  Yes                          528 (41.77)          33         6.25             Reference

  No                           736 (58.23)          61         8.29             1.19 (0.74--1.91)

  Hypertension                                                                  

  No                           872 (68.99)          64         7.34             Reference

  Yes                          392 (31.01)          30         7.65             0.77 (0.46--1.29)

  Diabetes mellitus                                                             

  No                           1119 (88.53)         78         6.97             Reference

  Yes                          145 (11.47)          16         11.03            1.42 (0.76--2.65)

  Hyperlipidemia                                                                

  No                           954 (75.47)          66         6.92             Reference

  Yes                          310 (24.53)          28         9.03             1.37 (0.81--2.30)

  History of stroke                                                             

  No                           1239 (98.02)         92         7.43             Reference

  Yes                          25 (1.98)            2          8.00             0.87 (0.19--4.02)

  Family history of COPD                                                        

  No                           1255 (99.29)         92         7.33             Reference

  Yes                          9 (0.71)             2          22.22            3.97 (0.70--22.51)

  Family history of asthma                                                      

  No                           1237 (97.86)         94         7.60             

  Yes                          27 (2.14)            0          0                NS

  History of angina pectoris                                                    

  No                           1211 (95.81)         89         7.35             Reference

  Yes                          53 (4.19)            5          9.43             0.80 (0.29--2.20)

  FVC, L (meanness)            86.69 ± 12.69                                    

  FEV1, L (mean ± SD)          90.40 ± 14.17                                    

  \% FEV1/FVC                  80.63 ± 8.27                                     

  COPD (FEV1/FVC)                                                               

  \<0.7                        94 (7.44)                                        

  ≥0.7                         1170 (92.56)                                     
  --------------------------------------------------------------------------------------------------

\* Adjusted for age, sex, education, smoking status, body mass index (BMI), drinking status, physical activity, hypertension, diabetes mellitus, hyperlipidemia, history of stroke and angina pectoris, and family history of chronic obstructive pulmonary disease (COPD) and asthma. NS, non-significant; OR, odds ratio; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.
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###### 

Distributions of PM~2.5~ PM~10~ and NO~2~.

  Length of exposure   Pollutant (μg/m^3^)   Mean (SD)      Median   IQR            Range
  -------------------- --------------------- -------------- -------- -------------- --------------
  5 years              PM~2.5~               35.82 (5.49)   37.07    6.64           14.94--46.5
  PM~10~               53.56 (4.40)          52.81          5.53     39.18--69.21   
  NO~2~                45.63 (17.68)         49.83          18.38    3.34--118.94   
  3 years              PM~2.5~               33.83 (5.62)   35.22    7.05           14.49--46.24
  PM~10~               50.98 (4.30)          50.17          5.44     38.87--67.32   
  NO~2~                44.64 (17.65)         48.6           18.87    3.34--135.87   
  1 year               PM~2.5~               33.39 (6.05)   34.97    7.26           14.52--48.08
  PM~10~               50.68 (4.57)          49.53          6.39     39.56--73.34   
  NO~2~                44.81 (17.75)         49.17          18.05    3.50--132.97   

PM~2.5~, particulate matter with an aerodynamic diameter of ≤2.5 μm; PM~10~, particulate matter with an aerodynamic diameter ≤10 μm; IQR, interquartile range.
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###### 

Logistic regression analyses of crude and adjusted associations between air pollutants (3-year averages) and COPD (n = 1264).

  Air Pollutants \*                   COPD                
  ----------------------------------- ------------------- -------------------
  NO~2~ (μg/m^3^)                                         
  Lowest tertile (\<41.0)             Reference           Reference
  Medium tertile (≥41.0 and \<53.8)   1.28 (0.73--2.25)   1.39 (0.77--2.52)
  Highest tertile (≥53.8)             1.93 (1.14--3.27)   1.83 (1.04--3.21)
  *p* for trend                                           0.012
  Per 10 μg/m^3^ increase             1.13 (0.99--1.27)   1.14 (1.00--1.30)
  PM~10~ (μg/m^3^)                                        
  Lowest tertile (\<48.5)             Reference           Reference
  Medium tertile (≥48.5 and \<52.2)   1.17 (0.68--2.01)   1.23 (0.70--2.15)
  Highest tertile (≥52.2)             1.51 (0.90--2.54)   1.57 (0.92--2.69)
  *p* for trend                                           0.113
  Per 10 μg/m^3^ increase             1.38 (0.87--2.21)   1.39 (0.85--2.25)
  PM~2.5~ (μg/m^3^)                                       
  Lowest tertile (\<32.7)             Reference           Reference
  Medium tertile (≥32.7 and \<37.1)   1.43 (0.82--2.48)   1.54 (0.86--2.75)
  Highest tertile (≥37.1)             1.77 (1.04--3.02)   1.79 (1.02--3.13)
  *p* for trend                                           0.035
  Per 10 μg/m^3^ increase             1.32 (0.88--1.97)   1.34 (0.89--2.02)

\* Air pollutant concentrations are three-year averages. ^†^ Adjusted for age, sex, education, smoking status, body mass index, drinking status, physical activity, hypertension, diabetes mellitus, hyperlipidemia, history of stroke and angina pectoris, and family history of COPD and asthma.

ijerph-15-00363-t004_Table 4

###### 

Associations between air pollutants (10 μg/m^3^) and lung function (n = 1264).

  Parameter    Length of exposure    Air Pollutant (μg/m^3^)   Crude                 Adjusted \*
  ------------ --------------------- ------------------------- --------------------- ---------------------
  FVC (l)      5 years               NO~2~                     0.35 (−0.05, 0.75)    0.18 (−0.22, 0.59)
  PM~10~       −1.38 (2.97, 0.21)    −1.52 (−3.10, 0.05)                             
  PM~2.5~      −0.61 (−1.89, 0.66)   −0.62 (−1.89, 0.65)                             
  3 years      NO~2~                 0.33 (−0.06, 0.73)        0.18 (−0.22, 0.58)    
  PM~10~       −1.52 (−3.14, 0.11)   −1.73 (−3.35, −0.12)                            
  PM~2.5~      −0.83 (−2.08, 0.41)   −0.85 (−2.10, 0.39)                             
  1 year       NO~2~                 0.27 (−0.13, 0.66)        0.11 (−0.28, 0.52)    
  PM~10~       −1.46 (−2.99, 0.07)   −1.77 (−3.29, −0.25)                            
  PM~2.5~      −0.80 (−1.96, 0.36)   −0.85 (−2.01, 0.30)                             
  FEV~1~ (l)   5 years               NO~2~                     0.19 (−0.25, 0.63)    0.11 (−0.33, 0.56)
  PM~10~       −1.58 (−3.36, 0.19)   −1.73 (−3.50, 0.03)                             
  PM~2.5~      −0.81 (−2.24, 0.61)   −0.86 (−2.28, 0.56)                             
  3 years      NO~2~                 0.19 (−0.25, 0.64)        0.13 (−0.32, 0.58)    
  PM~10~       −1.62 (−3.44, 0.19)   −1.85 (−3.65, −0.05)                            
  PM~2.5~      −0.83 (−2.22, 0.57)   −0.94 (−2.33, 0.45)                             
  1 year       NO~2~                 0.15 (−0.29, 0.59)        0.09 (−0.36, 0.53)    
  PM~10~       −1.13 (−2.84, 0.58)   −1.46 (−3.16, 0.24)                             
  PM~2.5~      −0.78 (−2.07, 0.51)   −0.96 (−2.25, 0.32)                             
  FEV~1~/FVC   5 years               NO~2~                     −0.07 (−0.32, 0.19)   −0.05 (−0.29, 0.19)
  PM~10~       0.05 (−0.99, 1.08)    0.09 (−0.93, 1.10)                              
  PM~2.5~      0.00 (−0.83, 0.84)    −0.09 (−1.03, 0.85)                             
  3 years      NO~2~                 −0.04 (−0.30, 0.22)       −0.03 (−0.28, 0.21)   
  PM~10~       0.11 (−0.95, 1.17)    0.16 (−0.89, 1.21)                              
  PM~2.5~      0.08 (−0.73, 0.90)    0.02 (−0.89, 0.93)                              
  1 year       NO~2~                 −0.04 (−0.30, 0.22)       −0.03 (−0.27, 0.21)   
  PM~10~       0.28 (−0.72, 1.28)    0.40 (−0.57, 1.37)                              
  PM~2.5~      0.00 (−0.75, 0.76)    −0.00 (−0.85, 0.85)                             

\* Adjusted for age, sex, education, smoking status, body mass index, drinking status, physical activity, hypertension, diabetes mellitus, and a history of stroke, COPD, and asthma.
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###### 

Changes in FVC and FEV~1~ associated with a 10 μg/m^3^ increase in pollutants (3-year average) (n = 1264).

  Parameter             Stratified Characteristics   Air Pollutants                                
  --------------------- ---------------------------- ---------------------- ---------------------- --
  FVC                   Age                                                                        
  \<57                  −0.31 (−0.87, 0.24)          −0.97 (−3.19, 1.25)    −1.63 (3.33, 0.01)     
  ≥57                   0.48 (−0.05, 1.01)           −2.39 (−4.67, −0.11)   −0.57 (2.41, 1.28)     
  *p* for interaction   0.545                        0.089                  0.252                  
  Sex                                                                                              
  Male                  0.21 (−0.36, 0.79)           −2.69 (−4.92, −0.46)   −0.85 (−2.72, 1.02)    
  Female                0.14 (−0.36, 0.63)           −0.98 (−3.27, 1.32)    −1.04 (−2.75, 0.68)    
  *p* for interaction   0.530                        0.403                  0.787                  
  Body mass index                                                                                  
  \<24                  −0.03 (−0.64, 0.58)          −2.25 (−4.64, 0.15)    −0.66 (−2.52, 1.20)    
  ≥24                   0.29 (−0.23, 0.82)           −1.33 (−3.48, 0.83)    −1.35 (−2.99, 0.29)    
  *p* for interaction   0.943                        0.993                  0.434                  
  Exercise                                                                                         
  Yes                   0.19 (−0.39, 0.76)           −1.68 (−4.35, 0.99)    −0.11 (−2.01, 1.79)    
  No                    0.19 (−0.34, 0.72)           −1.75 (−3.83, 0.34)    −1.76 (−3.49, −0.04)   
  *p* for interaction   0.653                        0.796                  0.171                  
  Education                                                                                        
  \<High school         0.59 (−0.19, 0.14)           −4.26 (−7.27, −1.26)   −0.87 (−3.73, 1.99)    
  ≥High school          0.03 (−0.42, 0.49)           −0.77 (−2.62, 1.09)    −0.82 (−2.22, 0.58)    
  *p* for interaction   0.193                        0.065                  0.939                  
  Smoking                                                                                          
  Current smoker        0.31 (−0.76, 1.39)           −2.53 (−6.95, 1.92)    −0.15 (−3.23, 2.93)    
  Former smoker         0.00 (−0.82, 0.82)           −3.61 (−6.93, −0.29)   −0.31 (−3.27, 2.65)    
  Non-smoker            0.27 (−0.23, 0.77)           −1.43 (−3.45, 0.58)    −1.57 (−3.16, 0.02)    
  *p* for interaction   0.935                        0.815                  0.412                  
  Age                                                                                              
  \<57                  −0.27 (−0.80, 0.26)          0.18 (−1.99, 2.35)     −0.21 (−1.97, 1.54)    
  ≥57                   0.33 (−0.25, 0.90)           −3.42 (−6.12, −0.72)   −1.89 (−4.03, 0.25)    
  *p* for interaction   0.870                        0.007                  0.273                  
  Sex                                                                                              
  Male                  0.18 (−0.50, 0.86)           −2.64 (−5.20, −0.01)   −0.64 (−2.69, 1.41)    
  Female                0.05 (−0.51, 0.61)           −1.07 (−3.68, 1.53)    −1.41 (−3.34, 0.53)    
  *P* for interaction   0.564                        0.482                  0.581                  
  Body mass index                                                                                  
  \<24                  −0.08 (−0.73, 0.58)          −1.34 (−3.94, 1.26)    −1.28 (−3.29, 0.72)    
  ≥24                   0.23 (−0.38, 0.84)           −2.49 (−4.99, 0.01)    −1.11 (−3.02, 0.80)    
  *p* for interaction   0.902                        0.276                  0.853                  
  Exercise                                                                                         
  Yes                   0.04 (−0.57, 0.65)           −1.95 (−4.87, 0.98)    0.24 (−1.79, 0.23)     
  No                    0.19 (−0.40, 0.79)           −1.57 (−3.89, 0.76)    −2.03 (−3.95, −0.10)   
  *p* for interaction   0.976                        0.971                  0.107                  
  Education                                                                                        
  \<High school         0.63 (−0.33, 1.59)           −5.99 (−9.66, −2.32)   −3.03 (−5.98, −0.09)   
  ≥High school          −0.03 (−0.54, 0.47)          −0.23 (−2.29, 0.18)    −0.03 (−1.59, 0.15)    
  *p* for interaction   0.201                        0.008                  0.092                  
                        Smoking                                                                    
  Current smoker        −0.01 (−1.25, 1.14)          −1.87 (−6.78, 3.04)    −2.51 (−5.89, 0.87)    
  Former smoker         0.16 (−0.65, 0.97)           −3.51 (−7.48, 0.46)    −0.45 (−3.54, 2.65)    
  Non-smoker            0.21 (−3.00, 0.72)           −1.60 (−3.88, 0.68)    −1.02 (−2.81, 0.78)    
  *p* for interaction   0.709                        0.839                  0.660                  

All models were adjusted for age, sex, education, smoking status, body mass index, drinking status, physical activity, hypertension, diabetes mellitus, and a history of stroke, COPD, asthma, and angina pectoris. Stratified characteristics were not included as confounders.
